The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah biochemist whose discoveries helped make the drug happen worries government cuts ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

"This really has the possibility of ending HIV transmission," said Greg Millett, public policy director at The Foundation for ...

The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year ...

With the 12 specialised key population clinics in South Africa funded by the US government, and now shuttered, getting treatment at government clinics has been difficult, if not impossible ...

But HIV never truly goes away. It lies dormant in the body and can reemerge if medications are stopped. That’s how the virus evades antiretroviral drugs and the body’s immune system. “HIV treatment is ...

HIV-1 would henceforth be known as Lentivirus humimdef1. SARs-CoV-2, the virus that causes Covid, would be known as ... Ideally, the new names would convey information about structure and ...

Sundquist’s research focuses on understanding how the HIV virus is built on a molecular level and how it interacts with the body to infect and spread through cells. By purifying and analyzing the ...

Env trimers have been engineered to mimic the native structure of the HIV Env on the surface of the HIV virion,” shared first author Dr. William Hahn, a Clinical Assistant Professor at the University ...